Anaplastic Lymphoma Kinase I1171N
1 clinical trials · Condition
◉ Watch Anaplastic Lymphoma Kinase I1171N
| Record | Firm | Date |
|---|---|---|
| A Real World Study of Ensartinib in Advanced ALK-positive NSCLC (NCT05498064) | Peking Union Medical College Hospital | 2022-05-13 |
Track Anaplastic Lymphoma Kinase I1171N automatically
Every clearance here is in the API, with alerts when new ones post.